KZR vs NSC · $53.9M cap vs P/E 18, rev $6.46B
Kezar Life Sciences Inc (KZR) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
KZR currently screens at market cap $53.9M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the KZR and NSC stock pages for the full models.
Not investment advice.